Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

EKF Diagnostics Announces Milestone for Hemo Control Hemoglobin Analyzer

Published: Monday, March 18, 2013
Last Updated: Monday, March 18, 2013
Bookmark and Share
33,333rd Hemo Control point-of-care analyzer released since 2003.

EKF Diagnostics has announced that the 33,333rd Hemo Control hemoglobin analyzer has been built at EKF’s manufacturing facility in Barleben, Germany.

Providing lab quality results within 25 seconds for both hemoglobin and hematocrit from one simple test, and with a CV of <2%, this robust analyzer has gained professional approval globally since the first Hemo Control was sold to Oman in 2003 - and is still in use.

In the last few years EKF has developed the Hemo Control range to include a data management version (Hemo Control Manager), a device that delivers results in just 10 seconds (Hemo Speed) and also launched a unique innovation in microcuvette technology - the NXT microcuvette.

This novel device delivers precise and easy sampling that also minimizes waste and cost.

The NXT microcuvette incorporates two unique features - an air gap that ensures bubble-free testing and a large blood collection opening that makes patient sampling more accurate and simpler to use than many alternatives on the market.

Data management options for Hemo Control have also been enhanced over the past decade to ensure simple management of patient data.

The Hemo Control Manager enables users to quickly and securely manage and analyze test results.

Up to 4000 patient results can be stored on the analyzer itself, with the option to seamlessly link to a PC and transfer data to an Information Management System.

Barcode identification of patients, operators and control levels further simplify data management.

Hemo Control was first launched for use in blood banks, but has since been used in a variety of clinical settings, including pregnancy and malnutrition screening programs around the world, from the USA to South Korea and Russia to Tanzania.

This versatility is a direct result of the analyzer’s durability and features, such as the integrated rechargeable battery and maintenance-free operation, which means that Hemo Control is ideal for field studies.

“We believe the key to Hemo Control’s continuing worldwide success is the quality of its results and reliability of the technology. The NXT microcuvette’s bubble-free sampling technology means that costs are reduced and patient discomfort is kept to a minimum,” commented Julian Baines, Group CEO, EKF Diagnostics Holdings plc.

Baines continued, “A decade on from its launch Hemo Control is more popular than ever before, and sales of devices and microcuvettes continue to grow. Our success in winning large government orders in Mexico, Peru and Tanzania, as well as our increasing market share in the USA, demonstrates the strength of the brand in a very competitive market.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EKF Diagnostics’ Growth Drives New Role Creation
Expanding business welcomes new faces to further strengthen IVD expertise and new product development.
Saturday, July 18, 2015
EKF Diagnostics Collaborates with Joslin Diabetes Center
Supporting the ongoing clinical and commercial development of early Diabetic Kidney Disease biomarkers.
Monday, November 17, 2014
Studies Validate EKF Diagnostics’ Early Stage Test for Progressive DKD
Independent scientific evidence confirms novel sTNFR1/2 biomarkers can accurately predict end-stage renal disease, up to 10 years in advance.
Friday, May 23, 2014
New Clinical Diagnostics Distributor Program Enhances EKF Customer Service
EKF Diagnostics appoints Simona Carnielli as new EMEA Distribution Manager.
Thursday, May 08, 2014
EKF Diagnostics Acquires Selah Genomics and DiaSpect Medical
Combined with the recent acquisition of Seperation Technology the purchases strengthen EKF’s product and services offering.
Tuesday, April 22, 2014
EKF Diagnostics Acquires Separation Technology
Acquisition complements EKF’s existing offering in the hemoglobin testing market place.
Thursday, March 27, 2014
PointMan™ Enriches Low-level DNA Mutations from Whole Blood
Ultra-sensitive PointMan™ enables blood sampling instead of tissue biopsies for cancer patient mutation status assessment.
Wednesday, January 22, 2014
Scientific News
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
New Test Detects All Viruses
A new test detects virtually any virus that infects people and animals, according to research at Washington University School of Medicine in St. Louis, where the technology was developed.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
Chip-Based Technology Enables Reliable Direct Detection of Ebola Virus
Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA.
Diagnostics Breakthrough Brings Viral Sequencing to Doctors’ Toolkit
New screening tool produces up to 10,000-fold improvement in viral matches compared with traditional high-throughput methods.
New Cell Type May Help Explain Dangerous Food Allergies
Researchers have discovered a new cell type that appears to drive life-threatening food allergies and may help explain why some people get severe allergic reactions and others do not.
Molecular Diagnostics At Home
Electrochemical test's sensing principle may be generalized to many different targets, leading to inexpensive devices that could detect dozens of disease markers in less than 5 minutes.
DNA Alterations as Among Earliest to Occur in Lung Cancer Development
Genetic footprints of precancer detectable in some blood samples.
New, Improved Approach To Mammograms
Detecting breast cancer in women with dense mammary tissues could become more reliable with a new mammogram procedure that researchers have now tested in pre-clinical studies of mice.
Undiagnosed Diseases Network Launches Online Application Portal
UDN Gateway enables patients to apply to national network of clinical sites.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos